Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
United Biomedical, Inc. (UBI), headquartered in the United States, is a prominent player in the medical laboratories industry, specialising in innovative diagnostic solutions. Founded in 1992, UBI has established itself as a leader in the development of advanced immunodiagnostic products and services, catering to a diverse range of healthcare needs.
With a focus on cutting-edge technologies, UBI offers unique products such as peptide-based diagnostics and therapeutic solutions that stand out for their precision and reliability. The company has achieved significant milestones, including numerous patents and collaborations that enhance its market position. UBI's commitment to quality and innovation has earned it recognition within the medical community, making it a trusted partner in advancing healthcare diagnostics.
+4 vs industry average
United Biomedical, Inc.’s score of 29 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medical Laboratories is among the least carbon-intensive industries
The Medical Laboratories industry has reduced its overall emissions by 28% since 2018
No reported emissions data is available for United Biomedical, Inc. yet.
United Biomedical, Inc., a medical laboratories company headquartered in the US, is committed to significant carbon emission reductions. While specific recent emissions data for United Biomedical, Inc. is not available, the company has outlined several ambitious targets.
United Biomedical, Inc. aims to reduce its Scope 1 and Scope 2 emissions to near zero by mid-decade, specifically by 2025. This forms part of a broader commitment to reduce Scope 1 and Scope 2 emissions by 30% from 2020 levels by 2030. These targets are absolute reduction goals, with a focus on near-term achievements.
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more